Dyne Therapeutics (DYN) Capital Expenditures (2019 - 2026)
Dyne Therapeutics (DYN) reported Capital Expenditures of $1.51 million for Q2 2026, compared with $60,000 a year earlier and up 585.1% from the prior quarter.
Powered by 
Analysis
Dyne Therapeutics (DYN) Capital Expenditures (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Dyne Therapeutics' Capital Expenditures came in at $19.48 million, up 722.5% year-over-year; for FY2025, it came in at $18.79 million, up 690.8% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 74.5% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $2.38 million in FY2024 (+225.9%), $729,000 in FY2023 (-76.2%), $3.07 million in FY2022 (-15.2%) and $3.62 million in FY2021 (+211.6%).
- Five-year quarterly Capital Expenditures spans a low of $60,000 in Q2 2025 and a high of $17.75 million in Q3 2025.
- Year over year, Capital Expenditures gained in two of the last four quarters, with growth averaging 73.7%.
- The high point for year-over-year Capital Expenditures in five years was Q3 2021 (growth of 464.7%); the low point was Q2 2025 (a decline of 93.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.10 Bn | 1,100.69 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.67 Bn | 534.20 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 504.61 Bn | 477.72 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 368.03 Bn | 322.41 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.24 Bn | 262.23 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.77 Bn | 235.46 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.62 Bn | 164.81 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Dyne Therapeutics | 2.73 Bn | -1.04 Bn | - | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 484,000.00 |
| Sep 30, 2025 | 19.19 Mn |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 981,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 857,000.00 |
| Mar 31, 2024 | 191,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Sep 30, 2023 | 167,000.00 |
| Jun 30, 2023 | 250,000.00 |
| Mar 31, 2023 | 230,000.00 |
| Dec 31, 2022 | 519,000.00 |
| Sep 30, 2022 | 886,000.00 |
| Jun 30, 2022 | 261,000.00 |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 881,000.00 |
API Access
Dyne Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DYN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "DYN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DYN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();